Array CGH

Array Comparative Genomic Hybridization (ArrayCGH) test, a microarray-based technique and the most precise tool available today that helps to detect the unbalanced structural and numerical chromosomal abnormalities that exist on cancer cells. The test is particularly helpful when a patient may be diagnosed with a cancer of unknown origin. In such cases, ArrayCGH helps point the doctor in the right direction by identifying chromosomal abnormalities associated with specific types of cancer.

How does ArrayCGH work?

• The ArrayCGH is used to identify chromosomal abnormalities in a patient that could lead to cancer.
• It analyzes the differences between a patient’s DNA and the reference control DNA and provides unique and personalized chromosomal analysis results.
• The process involves isolating circulating tumor cells (CTCs) from blood, extracting their DNA, and analyzing genetic characteristics through a microarray-based technique.

Why choose the ArrayCGH test?

ArrayCGH is a specific molecular cytogenetic method forscreening the genome and identifying any abnormalities which might be associated with cancer.

• With the detection of abnormalities in the chromosomes, ArrayCGH enables us to identify the primary origin of the tumor.
• It enables precise and fast detection of abnormalities in the entire genome sequence with very high resolution.
• It provides clinicians with personalized chromosomal analysis for their patients’ unique cancer journey.